PATENT CLAIM ANALYSIS

Application Number: 16288349
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "002700"]

Abstract:
Disclosed are methods for identifying patients at increased risk of developing disseminated staphylococcal infection, which includes the steps of determining that the patient has a mutation in one or more genes selected from a MPDZ network gene, a CGNL1 network gene, a PRKRIR network gene, a MED26 network gene, a tight junction protein gene, or an immune modulator gene; and treating the patient for disseminated staphylococcal infection. Also disclosed are solid substrates and/or assays useful for carrying out the disclosed methods.

Claim (Index 6):
The method of  claim 1  wherein said antibiotic comprises vancomycin.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.57895
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14681673', '15978332', '12892679', '13024084', '13809960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6971213805081997
- 35 USC 102 Novelty (BERT): 0.5362176169599305
- Combined Prediction Score: 0.6810310041533728
- Mean Citation Score: 218.294688
- Max Citation Score: 348.4317
- Similarity Product: 304.06186081733114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test